Cargando…
Integration of whole genome sequencing into a healthcare setting: high diagnostic rates across multiple clinical entities in 3219 rare disease patients
BACKGROUND: We report the findings from 4437 individuals (3219 patients and 1218 relatives) who have been analyzed by whole genome sequencing (WGS) at the Genomic Medicine Center Karolinska-Rare Diseases (GMCK-RD) since mid-2015. GMCK-RD represents a long-term collaborative initiative between Karoli...
Ejemplares similares
-
From cytogenetics to cytogenomics: whole-genome sequencing as a first-line test comprehensively captures the diverse spectrum of disease-causing genetic variation underlying intellectual disability
por: Lindstrand, Anna, et al.
Publicado: (2019) -
Epilepsy syndromes, etiologies, and the use of next‐generation sequencing in epilepsy presenting in the first 2 years of life: A population‐based study
por: Stödberg, Tommy, et al.
Publicado: (2020) -
SLC12A2 mutations cause NKCC1 deficiency with encephalopathy and impaired secretory epithelia
por: Stödberg, Tommy, et al.
Publicado: (2020) -
Individualised human phenotype ontology gene panels improve clinical whole exome and genome sequencing analytical efficacy in a cohort of developmental and epileptic encephalopathies
por: Henry, Olivia J., et al.
Publicado: (2023) -
Loqusdb: added value of an observations database of local genomic variation
por: Magnusson, Måns, et al.
Publicado: (2020)